Study Comparing the CYPHER® ELITE™ to the CYPHER® Bx VELOCITY® Sirolimus-Eluting Stent Systems
Not Applicable
- Conditions
- Coronary Artery DiseaseCoronary Atherosclerosis
- Interventions
- Device: CYPHER® Bx VELOCITY® Sirolimus-eluting Stent SystemDevice: CYPHER® ELITE™ Sirolimus-Eluting Stent System
- First Posted Date
- 2008-07-15
- Last Posted Date
- 2014-01-20
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 678
- Registration Number
- NCT00715884
- Locations
- 🇺🇸
Washington Hospital Center, Washington, District of Columbia, United States
Conor Cobalt Chromium Reservoir Based Stent With Sirolimus Elution in Native Coronary Artery Lesions
Phase 2
Terminated
- Conditions
- Coronary Disease
- First Posted Date
- 2008-07-14
- Last Posted Date
- 2012-10-25
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 3
- Registration Number
- NCT00714883
- Locations
- 🇱🇻
P. Stradina Clinical - University Hospital, Riga, Latvia
🇩🇪Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany
Comparing Angioplasty and DES in the Treatment of Subjects With Ischemic Infrapopliteal Arterial Disease
Phase 4
Completed
- Conditions
- Peripheral Arterial Diseases
- Interventions
- Device: balloon angioplastyDevice: drug eluting stent
- First Posted Date
- 2008-03-21
- Last Posted Date
- 2011-03-15
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 200
- Registration Number
- NCT00640770
- Locations
- 🇩🇪
Universität Leipzig - Herzzentrum, Leipzig, Germany
Comparison of the Conor Sirolimus-eluting Coronary Stent to the Taxus Liberte Paclitaxel-eluting Coronary Stent in the Treatment of Coronary Artery Lesions
Not Applicable
Terminated
- Conditions
- Coronary Atherosclerosis
- Interventions
- Device: NEVO™ Sirolimus-eluting Coronary Stent SystemDevice: Drug-eluting stent (TAXUS Liberte Paclitaxel-eluting Coronary Stent System)
- First Posted Date
- 2008-02-01
- Last Posted Date
- 2012-10-25
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 394
- Registration Number
- NCT00606333
- Locations
- 🇧🇷
Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil
🇳🇿Mercy Angiography Unit, Epsom, Auckland, New Zealand
ECLIPSE Feasibility Trial (Ensure's Vascular Closure Device Speeds Hemostasis Trial) EU
Phase 1
Completed
- Conditions
- Angioplasty, Transluminal, Percutaneous CoronaryCoronary Arteriosclerosis
- Interventions
- Device: 7F Ensure Medical Vascular Closure Device
- First Posted Date
- 2007-12-17
- Last Posted Date
- 2012-02-28
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 93
- Registration Number
- NCT00574691
- Locations
- 🇩🇪
Herz-und Diabeteszentrum NRW, Bad Oeynhausen, Germany
Plug Arterial Closure System (PACS, 7F)
Phase 2
Completed
- Conditions
- Angioplasty, Transluminal, Percutaneous CoronaryCoronary Arteriosclerosis
- First Posted Date
- 2007-09-21
- Last Posted Date
- 2012-02-28
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 30
- Registration Number
- NCT00533156
- Locations
- 🇲🇽
Hospital Almater, Mexicali, Baja California, Mexico
Diabetes Drug Eluting Sirolimus Stent Experience in Restenosis Trial
Phase 4
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: CYPHER Sirolimus-eluting stentDevice: Bx SONIC bare metal stent
- First Posted Date
- 2007-07-06
- Last Posted Date
- 2010-02-04
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 150
- Registration Number
- NCT00497172
- Locations
- 🇮🇹
Azienda USL Ravenna - Ospedale santa Maria delle Croci, Ravenna, Italy
A Study of Diabetic Patients With De Novo Native Coronary Artery Lesions
Phase 4
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: CYPHER sirolimus-eluting stentDevice: uncoated Bx VELOCITY balloon-expandable stent
- First Posted Date
- 2007-07-03
- Last Posted Date
- 2009-12-03
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 200
- Registration Number
- NCT00495898
- Locations
- 🇩🇪
University of Essen, Essen, Germany
Feasibility Study With the Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in the Treatment of Diabetic Patients With Native Coronary Artery Lesions
Phase 1
Terminated
- Conditions
- Peripheral Vascular Diseases
- First Posted Date
- 2007-06-21
- Last Posted Date
- 2008-11-11
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 83
- Registration Number
- NCT00489164
- Locations
- 🇮🇳
Jaslok Hospital & Research Centre, Mumbai, India
🇮🇳Escorts Heart Institute & Research Centre, New Delhi, India
🇲🇾National Heart Institute, Kuala Lumpur, Malaysia
An Observational Registry Using Drug Eluting Stents (DES) in Patients in a Real-World Setting (DEScover Registry).
Completed
- Conditions
- Cardiovascular DiseasesVascular DiseaseArterial Occlusive DiseaseArteriosclerosisAtherosclerosis
- First Posted Date
- 2007-06-21
- Last Posted Date
- 2007-08-02
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 7759
- Registration Number
- NCT00489320
- Locations
- 🇺🇸
Rhode Island Hospital, Providence, Rhode Island, United States
© Copyright 2025. All Rights Reserved by MedPath